Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bayer Aktienges ADR
(OP:
BAYRY
)
7.790
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.790
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
7.790
Today's Range
7.790 - 7.790
52wk Range
6.820 - 13.19
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
September 16, 2024
Bayer's Phase 3 ARANOTE trial showed darolutamide plus androgen deprivation therapy (ADT) reduced the risk of radiological progression or death in metastatic hormone-sensitive prostate cancer patients...
Via
Benzinga
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
September 10, 2024
Roivant Sciences has licensed worldwide rights to develop and commercialize Bayer's mosliciguat for an upfront payment of $14 million and up to $280 million in future milestone payments.
Via
Benzinga
Performance
YTD
-16.95%
-16.95%
1 Month
-3.35%
-3.35%
3 Month
+11.29%
+11.29%
6 Month
+9.26%
+9.26%
1 Year
-40.53%
-40.53%
More News
Read More
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
August 30, 2024
Via
Benzinga
BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
July 25, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Glyphosate
Legal
ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
July 23, 2024
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
July 08, 2024
Via
InvestorPlace
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Via
InvestorPlace
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
June 05, 2024
Via
Benzinga
Exposures
Glyphosate
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Via
Talk Markets
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
May 27, 2024
Via
Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Via
Benzinga
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16, 2024
Via
Benzinga
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
May 10, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
May 02, 2024
Via
Benzinga
Exposures
Glyphosate
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
April 10, 2024
Via
Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
April 09, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
April 05, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Bayer-Backed Boundless Bio Falls After IPO
March 31, 2024
Via
Talk Markets
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
March 19, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Supply Chain
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
March 19, 2024
Via
Benzinga
Exposures
Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Glyphosate
Legal
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.